President of Harvard University highlights how the Dana-Farber Society is changing the future of cancer
The 29th Annual Dana-Farber Society Recognition Dinner was held at the Mandarin Oriental, Boston on May 14. The evening was dedicated to celebrating progress in cancer research and patient care made possible by the generosity of the Dana-Farber Society (DFS)—a group of individuals who have remembered Dana-Farber and the Jimmy Fund in their estate plans. Dana-Farber President and CEO, Laurie H. Glimcher, MD, began the evening by sharing her strategic vision for the future of Dana-Farber, and echoing the incredible impact the Society is making as forward-thinking donors. Keynote speaker Larry S. Bacow, 29th President of Harvard University, emphasized that the innovation and discovery happening here in Boston—at Dana-Farber and in collaboration with Harvard—is helping to shape the future of cancer medicine and bring new treatments to our patients, and to all cancer patients across the globe.
“If you want to have hope, all you have to look at is the work that our scientists and physicians are doing to give people hope every day of the week.”
Legacy gifts from DFS members have advanced Dana-Farber’s patient care and research initiatives since 1990. The group began with 90 members and now includes more than 1,200 people from around the world. Though much has been accomplished, there is still more work to be done. By joining the DFS, donors enable Dana-Farber research teams to test out-of-the-box ideas, build collaborations, and deliver compassionate cancer care for future generations to come.
Learn more about the Dana-Farber Society and how you can create a lasting legacy through a planned gift to support Dana-Farber and the Jimmy Fund.